392 related articles for article (PubMed ID: 15249687)
21. Control of viral infectivity by tripartite motif proteins.
Towers GJ
Hum Gene Ther; 2005 Oct; 16(10):1125-32. PubMed ID: 16218773
[TBL] [Abstract][Full Text] [Related]
22. Role of Human TRIM5α in Intrinsic Immunity.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():97. PubMed ID: 22435067
[TBL] [Abstract][Full Text] [Related]
23. Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
Diaz-Griffero F; Kar A; Lee M; Stremlau M; Poeschla E; Sodroski J
Virology; 2007 Dec; 369(2):400-10. PubMed ID: 17920096
[TBL] [Abstract][Full Text] [Related]
24. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
[TBL] [Abstract][Full Text] [Related]
25. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
26. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
27. Potent restriction of HIV-1 and SIVmac239 replication by African green monkey TRIM5α.
Coren LV; Trivett MT; Jain S; Ayala VI; Del Prete GQ; Ohlen C; Ott DE
Retrovirology; 2015 Feb; 12():11. PubMed ID: 25809491
[TBL] [Abstract][Full Text] [Related]
28. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E; Berthoux L; Luban J
J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
[TBL] [Abstract][Full Text] [Related]
29. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
Ohkura S; Stoye JP
J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
[TBL] [Abstract][Full Text] [Related]
30. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses.
Schaller T; Ylinen LM; Webb BL; Singh S; Towers GJ
J Virol; 2007 Sep; 81(18):10055-63. PubMed ID: 17609268
[TBL] [Abstract][Full Text] [Related]
31. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
[TBL] [Abstract][Full Text] [Related]
32. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
Berthoux L; Towers GJ; Gurer C; Salomoni P; Pandolfi PP; Luban J
J Virol; 2003 Mar; 77(5):3167-80. PubMed ID: 12584341
[TBL] [Abstract][Full Text] [Related]
33. Restriction factors: a defense against retroviral infection.
Bieniasz PD
Trends Microbiol; 2003 Jun; 11(6):286-91. PubMed ID: 12823946
[TBL] [Abstract][Full Text] [Related]
34. A dominant-negative effect of cynomolgus monkey tripartite motif protein TRIM5alpha on anti-simian immunodeficiency virus SIVmac activity of an African green monkey orthologue.
Nakayama EE; Maegawa H; Shioda T
Virology; 2006 Jun; 350(1):158-63. PubMed ID: 16647098
[TBL] [Abstract][Full Text] [Related]
35. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
36. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L; Sebastian S; Sayah DM; Luban J
J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
[TBL] [Abstract][Full Text] [Related]
37. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
38. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
[TBL] [Abstract][Full Text] [Related]
39. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
40. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
Ohkura S; Yap MW; Sheldon T; Stoye JP
J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
